Disturbed platelet aggregation as a factor of diabetic maculopathy and diabetic macular edema in patients with nonproliferative diabetic retinopathy in type 2 diabetes mellitus

S.Yu. Mogilevskyy, Yu.O. Panchenko, S.V. Ziablitsev, L.V. Natrus


Background. The analysis of current data makes it possible to suggest that the pathogenetic factors of diabetes mellitus (DM) can provoke the proaggregant status of platelets and cause microcirculatory disturbances in the eye membranes and the development of diabetic maculopathy (DMP) and diabetic macular edema (DMA). The purpose of the study is to analyze the disturbed platelet aggregation in DMA and DMP in nonproliferative diabetic retinopathy (NPDR) with type 2 DM. Materials and methods. The study included 32 patients (32 eyes) with type 2 DM, in whom mild (14 patients, 14 eyes) and moderate (18 patients, 18 eyes) stages of NPDR were detected according to the Early Treatment Diabetic Retinopathy Study classification. Adenosine diphosphate, adrenaline, angiotensin-2 (Ang-2), platelet-activating factor (PAF), and collagen were used to study platelets in vitro. Platelet aggregation was evaluated using turbidimetric method on Chronolog analyzer (USA). Results. Patients with DMP in moderate NPDR showed greater reactivity of platelets to Ang-2, PAF, and adrenaline than with the mild stage (p < 0.01). This phenomenon reflected an increase in platelet aggregation due to violations of sympathoadrenal and renin-angiotensin systems and an increase in the severity of inflammation. Platelet hyperreactivity to Ang-2 was the cause of DMA in patients with DMP at moderate stage of NPDR. Conclusions. Pathogenetic factors of DM can provoke proaggregant status of platelets and, thus, cause microcirculatory disturbances in the eye membranes, which is accompanied by the development of DMP and DMA.


diabetic maculopathy; diabetic macular edema; nonproliferative diabetic retinopathy; platelet aggregation


Macular integrity assessment to determine the association between macular microstructure and functional parameters in diabetic macular edema / J.W. Wang, C.H. Jie, Y.J. Tao [et al.] // Int. J. Ophthalmol. — 2018. — Vol. 11(7). — P. 1185-1191.

Diabetic retinopathy: Breaking the barrier / R.S. Eshaq, A.M.Z. Aldalati, J.S. Alexander, N.R. Harris // Pathophysiology. — 2017. — Vol. 24(4). — P. 229-241.

Shilpi K. А study of platelet indices in type 2 diabetes mellitus patients / K. Shilpi, R.M. Potekar // Indian J. Hematol. Blood Transfus. — 2018. — Vol. 34(1). — P. 115-120.

Cunha-Vaz J. The blood-retinal barrier in the management of retinal disease: EURETINA Award Lecture / J. Cunha-Vaz // Ophthalmologica. — 2017. — Vol. 237(1). — P. 1-10.

Deppermann C. Platelets and vascular integrity / C. Deppermann // Platelets. — 2018. — Vol. 15. — P. 1-7.

Ticagrelor, a P2Y12 antagonist, attenuates vasculardysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice / B. Ganbaatar, D. Fukuda, H.M. Salim [et al.] // Atherosclerosis. — 2018. — Vol. 275. — P. 124-132.

Blum A. Vascular responsiveness in type 2 diabetes mellitus (T2DM) / A. Blum, D. Socea, R. Sirchan // QJM. — 2016. — Vol. 109(12). — P. 791-796.

Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration / A. Radziwon-Balicka, C.M. de la Rosa, B. Zielnik [et al.] // PLOS ONE. — 2013. — Vol. 8(3). — e59281.

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released / J.E. Italiano, J.L. Richardson, S. Patel-Hett [et al.] // Blood. — 2008. — Vol. 111(3). — P. 1227-1233.

Lally D.R. Vascular endothelial growth factor and diabetic macular edema / D.R. Lally, C.P. Shah, J.S. Heier // Surv. Ophthalmol. — 2016. — Vol. 61(6). — P. 759-768.

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab / J.K. Li, F. Wei, X.H. Jin [et al.] // Int. J. Ophthalmol. — 2015. — Vol. 8(6). — P. 1202-1206.

Constitutive activation of the renin-angiotensin system redu­ces visceral fat and improves glucose tolerance in mice / G.A. Favre, P. Lebrun, P. Lopez [et al.] // J. Renin Angiotensin Aldosterone Syst. — 2014. — Vol. 15(4). — P. 396-409.

Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy / J.H. Kim, J.H. Kim, Y.S. Yu [et al.] // J. Cereb. Blood Flow. Metab. — 2009. — Vol. 29(3). — P. 621-628.

Porta M. The changing role of the endocrinologist in the care of patients with diabetic retinopathy / M. Porta, A.V. Taulaigo // Endocrine. — 2014. — Vol. 46(2). — P. 199-208.

Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial / F. Sharifipour, M. Razzaghi, A. Ramezani [et al.] // Int. Ophthalmol. — 2016. — Vol. 36(2). — P. 225-235.

Hypertensive retinopathy in a transgenic angiotensin-based model / N. Reichhart, N. Mezouar, V. Domenga-Denier [et al.] // Clin. Sci. (Lond.). — 2016. — Vol. 130(13). — P. 1075-1088.

Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli / V.M. Milenkovic, M. Brockmann, C. Meyer [et al.] // Am. J. Physiol. Renal. Physiol. — 2010. — Vol. 299(2). — F396-403.

Hudz A.S. Functional status of platelets in type 2 diabetes patients showing no diabetic fundus changes / A.S. Hudz, S.Iu. Mogilevskyy, M.L. Maksymtsiv // J. ophthalmol. (Ukraine). — 2017. — Vol. 1. — P. 20-24.

Гудзь А.С. Функціональний стан тромбоцитів і порушення мікроциркуляції сітківки у пацієнтів, хворих на цукровий діабет 2-го типу / А.С. Гудзь, М.Л. Максимців // Архів офтальмології України. — 2017. — T. 2(8). — C. 27-32.

Протромбогенний фенотип тромбоцитів у пацієнтів із непроліферативною діабетичною ретинопатією / А.С. Гудзь, М.Л. Максимців, С.В. Зябліцев, С.Ю. Могілевський // Міжнародний ендокринологічний журнал. — 2018. — Т. 14, № 2. — С. 143-147. — DOI:–0721.14.2.2018.130558.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© "Publishing House "Zaslavsky", 1997-2020


   Seo анализ сайта